About Benchling
Benchling is a company based in San Francisco (United States) founded in 2012 by Ashu Singhal. Benchling has raised $411.9 million across 9 funding rounds from investors including Fidelity Investments, Franklin Templeton and Spark Capital. Benchling has completed 1 acquisition, including Overwatch Research. Benchling offers products and services including Benchling Bioresearch, Benchling Bioprocess, and Benchling In Vivo. Benchling operates in a competitive market with competitors including Helix, BioAge Labs, Ingenuity Systems, Genuity Science and NTxBio, among others.
- Headquarter San Francisco, United States
- Founders Ashu Singhal
- Stage Unicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Benchling, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$411.9 M (USD)
in 9 rounds
-
Latest Funding Round
$100 M (USD), Series F
Nov 18, 2021
-
Investors
Fidelity Investments
& 24 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Benchling
Benchling offers a comprehensive portfolio of products and services, including Benchling Bioresearch, Benchling Bioprocess, and Benchling In Vivo.
Platform for planning and recording experiments in biotech research.
Tools for end-to-end process development in biopharmaceuticals.
System for managing and analyzing in vivo study data.
People of Benchling
Unlock access to complete
Software Development Team
42 people
Product Management Team
30 people
Leadership Team
21 people
Finance and Accounting
12 people
Sales and Marketing
11 people
Human Resources and Administration
8 people
Legal and Compliance
5 people
Head Team
4 people
Unlock access to complete
Funding Insights of Benchling
Benchling has successfully raised a total of $411.9M across 9 strategic funding rounds. The most recent funding activity was a Series F round of $100 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Benchling
Benchling has secured backing from 25 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Fidelity Investments, Franklin Templeton and Spark Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long/short equity hedge fund and VC fim
|
Locked | Locked | Locked | |
|
Venture and private equity investments are managed with global diversification.
|
Locked | Locked | Locked | |
|
Long/short and long-only strategies are employed by the hedge fund.
|
Locked | Locked | Locked |
Investor details for Benchling
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Benchling
Benchling has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Overwatch Research.
Investment portfolio details for Benchling
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical data and workflows are managed through an online platform.
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Benchling
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Benchling
Detailed financials for Benchling
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Benchling Comparisons
Peer comparison for Benchling
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Benchling
Benchling operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, BioAge Labs, Ingenuity Systems, Genuity Science and NTxBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Provider of bio informatics platform to develops biologics and therapeutics
|
Detailed competitors of Benchling
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Benchling
Complete news archive for Benchling
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Benchling
Benchling was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Benchling is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Benchling is a funded company, having raised a total of $411.9M across 9 funding rounds to date.
Provider of a cloud-based bioinformatics platform for biotech research It includes the premier suite for molecular biology research: CRISPR guide design, automated Gibson and Golden Gate cloning, primer design, multiple sequence alignment, and more. Other apps include image analysis like gel annotation and colony counting and protocol design with spreadsheet functionality. The companys tools are cloud-based and so can be shared with people instantly.
Benchling's top competitors include Helix, BioAge Labs and NTxBio.
Benchling offers Benchling Bioresearch, Benchling Bioprocess, and Benchling In Vivo.
Benchling has made 1 acquisition, including Overwatch Research.
Benchling has 25 investors. Key investors include Fidelity Investments, Franklin Templeton, Spark Capital, Alkeon Capital Management, and Benchmark Email.
The valuation of Benchling is $6.1B as of Nov 2021.